A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.
about
DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent VirusMonocytes Phenotype and Cytokine Production in Human Immunodeficiency Virus-1 Infected Patients Receiving a Modified Vaccinia Ankara-Based HIV-1 Vaccine: Relationship to CD300 Molecules Expression.MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization.AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B
P2860
Q28554534-F001CF8F-5083-41DC-8A4B-F58A5EE2531DQ40091488-4D197B03-E090-4F3B-8A47-7E3A7013FD55Q40497816-1F091B34-4B30-4B9A-A4E6-058E1CCF8F3DQ41929341-CA276B88-41A3-4528-8696-67B05AF8EE38Q47375908-D9655C7A-36C2-48AF-8ADE-549049A34A3BQ55698444-A3EB482D-481C-4E70-8D73-71121D656E02Q57009763-FED87AA6-5566-4C51-8F64-DDB42BE97CAC
P2860
A Phase I Randomized Therapeutic MVA-B Vaccination Improves the Magnitude and Quality of the T Cell Immune Responses in HIV-1-Infected Subjects on HAART.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A Phase I Randomized Therapeut ...... -1-Infected Subjects on HAART.
@en
type
label
A Phase I Randomized Therapeut ...... -1-Infected Subjects on HAART.
@en
prefLabel
A Phase I Randomized Therapeut ...... -1-Infected Subjects on HAART.
@en
P2093
P2860
P50
P1433
P1476
A Phase I Randomized Therapeut ...... V-1-Infected Subjects on HAART
@en
P2093
Beatriz Perdiguero
Carlos Óscar Sánchez-Sorzano
Christian Brander
Jose M Gatell
José Luis Jiménez
Juan Carlos López Bernaldo de Quirós
Victoria Cepeda
P2860
P304
P356
10.1371/JOURNAL.PONE.0141456
P407
P50
P577
2015-11-06T00:00:00Z